Lauren Tyra

Director/Miembro de la Junta en Gregor Diagnostics, Inc. .

Consumer Services

Finance

Health Technology

Perfil

Lauren Tyra is currently the Director at Gregor Diagnostics, Inc. and the Chief Scientific Officer at Green Park & Golf Ventures LLC.
She completed her undergraduate degree at the University of North Texas and her doctorate degree at The University of Texas Southwestern Medical Center in 2017.

Cargos activos de Lauren Tyra

Empresas	Cargo	Inicio
Green Park & Golf Ventures LLC Green Park & Golf Ventures LLC Investment ManagersFinance Green Park & Golf Ventures LLC (Green Park & Golf Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.	Corporate Officer/Principal	01/03/2020
Gregor Diagnostics, Inc. Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI.	Director/Miembro de la Junta	-

Todos los cargos activos de Lauren Tyra

Formación de Lauren Tyra.

University of North Texas	Undergraduate Degree
The University of Texas Southwestern Medical Center	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lauren Tyra.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Green Park & Golf Ventures LLC Green Park & Golf Ventures LLC Investment ManagersFinance Green Park & Golf Ventures LLC (Green Park & Golf Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas.	Finance
Gregor Diagnostics, Inc. Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI.	Health Technology

Ver las conexiones de la empresa